✦ LIBER ✦
P-202 MDS development risk in CLL patients with prolonged cytopenia after fludarabine, cyclophosphamide and rituximab (FCR) régime
✍ Scribed by Jonasova, A.; Obrtlikova, P.; Siskova, M.; Cmunt, E.; Berkova, A.; Karban, J.; Svackova, K.; Trneny, M.
- Book ID
- 122836384
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 81 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.